pharma · SBRT · Covid19 · GRTX
Kailera Therapeutics
Galera Therapeutics
Kailera Therapeutics is a pharma organization headquartered in Waltham, USA. It trades on NYSE under ticker GRTX. Primary therapeutic focus areas include SBRT, Covid19, Head and Neck Cancer, Oral Mucositis, Esophagitis.
Company details
- Status
- Public
- HQ
- Waltham, Massachusetts, United States
- Founded
- 2024
- Employees
- 153
- Programs
- 17
- Drugs
- 7
- Patents
- 23
Quick answer
Kailera Therapeutics is a pharma organization headquartered in Waltham, USA. It trades on NYSE under ticker GRTX. Primary therapeutic focus areas include SBRT, Covid19, Head and Neck Cancer, Oral Mucositis, Esophagitis. NovaPharmaNews links 17 clinical program(s), 0 drug profile(s), and 23 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (9), phase 2 (7), phase 3 (1).
Company snapshot
Galera Therapeutics is focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.
- 17 active pipeline program(s) linked via ClinicalTrials.gov.
- 23 US patent(s) indexed to this assignee profile.
- 17 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Kailera Therapeutics. Not investment advice.
Recent coverage
Top assets
Lead pipeline drugs
- approved
- approved
- Marketed / approved
- approved
Active clinical programs
- Phase 3
- Phase 2
- Phase 2
- Phase 2
Momentum
Proprietary activity score for Kailera Therapeutics.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Competitor landscape
Therapeutic-area overlap peers from registry and pipeline signals.
- Peer + 0 momentum
Recent activity
Latest pipeline, patent, and corporate events for Kailera Therapeutics.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Kailera Therapeutics?
-
Is Kailera Therapeutics publicly traded?
-
What drugs does Kailera Therapeutics develop or market?
-
What are the latest developments for Kailera Therapeutics?
-
What therapeutic areas does Kailera Therapeutics focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.